Abstract

ObjectiveTo assess whether women of advanced age (≥35 years) with polycystic ovary syndrome (PCOS) have the same cumulative live birth rate (CLBR) as their age-matched controls with tubal factor infertility and to determine the influencing factors on the CLBRs of aged women.DesignA retrospective cohort study.Setting and PopulationA total of 160 women of advanced age (≥35 years) with PCOS and 1073 women with tubal factor infertility were included in our study. All patients underwent their first fresh cycles and subsequent frozen cycles within in one year in our centre from 2015 to 2020.MethodsTo determine independent influencing factors on the CLBRs of these aged patients, a multivariable Cox regression model of CLBR according to the transfer cycle type was constructed. Main outcome measure(s): CLBRs.ResultThe Cox regression model of the CLBRs indicated that there was no significant difference between the PCOS group and the tubal infertility group in terms of advanced age (HR, 0.95; 95% CI, 0.71-1.27, P=0.732). The CLBR significantly decreased for women of advanced reproductive age up to 37 years of age (HR, 0.46; 95% CI, 0.39-0.56, P<0.001). The CLBR increased by 63% when more than ten oocytes were retrieved (HR, 1.63; 95% CI, 1.34-1.98, P<0.001). Patients with an AMH level above 32.13pmol/l were likely to have a 72%(HR, 1.72; 95% CI, 1.08-2.73, = 0.023) and 34% (HR, 1.34; 95% CI, 1.07-1.68, P=0.010)improvement in CLBR compared to those with an AMH below 7.85pmol/l and 7.85-32.12pmol/l, respectively.ConclusionDespite the higher number of oocytes retrieved in PCOS patients, the reproductive window is not extended for PCOS patients compared with tubal factor infertility patients. Age, AMH and the number of oocytes retrieved play crucial roles in the CLBRs of patients of advanced age (≥35 years).

Highlights

  • Polycystic ovary syndrome (PCOS) is a widespread reproductive disorder that encompasses many associated health conditions and impacts various metabolic processes

  • There is no difference in the incidence of insulin resistance between the PCOS group and the tubal infertility group, the comparison between the two groups is meaningless due to low test rate in tubal infertility group

  • Regarding all transfer cycles outcomes, all patients were divided into two groups depending on whether a live birth was achieved (Table 2)

Read more

Summary

Introduction

Polycystic ovary syndrome (PCOS) is a widespread reproductive disorder that encompasses many associated health conditions and impacts various metabolic processes. This condition leads to an increased risk of insulin resistance (IR), type 2 diabetes, obesity, and cardiovascular disease. PCOS is the most common cause of menstrual irregularity that leads to infertility. Among all cases comprising couples seeking treatment for infertility, 30% are due to anovulation [3]. It is estimated that 90% of anovulation cases are due to PCOS [4]. For PCOS patients who exhibit CC resistance and letrozole failure, assisted reproductive technology (ART) may play a role in helping them to achieve pregnancy [4, 6]. In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) are the most popular ART treatments

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call